SCHEMBL6630700

SCHEMBL6630700

CCCC(N)Cc1nc2ccccc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UBE2T Q9NPD8 1/20 0.54
▸ ASIC3 Q9UHC3 1/20 0.54
▸ LOXL2 Q9Y4K0 1/20 0.48
▸ MAPT P10636 6/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ RAB9A P51151 6/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HTT P42858 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HPGD P15428 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849217 0.82 UBE2T (0.50) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL14478202 0.81 UBE2T (0.61) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL14478204 0.81 UBE2T (0.61) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL19214783 0.79 RAB9A (0.43) MAPTRAB9ANPC1SMN1; SMN2MAPK1
SCHEMBL20661476 0.77 CASP3 (0.45) RAB9ANPC1SMN1; SMN2MAPK1GAA
SCHEMBL2662248 0.77 UBE2T (0.59) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL16411256 0.77 L3MBTL1 (0.49) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL23222252 0.76 UBE2T (0.50) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL9217943 0.76 UBE2T (0.58) UBE2TASIC3LOXL2MAPTL3MBTL1
SCHEMBL12511 0.75 UBE2T (0.61) UBE2TASIC3MAPTL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 — — EP disclosed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 — — WO disclosed
Send feedback